1-6 of 6
Shujuan Wen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The research on the immune microenvironment of patients with relapse or refractory diffuse large b faced drug resistance to CD20/CD3 bispecific antibodies

Free
Shujuan Wen, Shan Li, Yiwei Zhou, Mei Wu, Yong Sun, Lin Zhu, Xin Hu, Li Guo, Hui Zhou
Journal: Blood
Blood (2025) 146 (Supplement 1): 7073.
https://doi.org/10.1182/blood-2025-7073
Published: 2025
Journal Articles

Tucidinostat plus R-CHOP in untreated MYC/BCL2 double-expressor diffuse large B-cell lymphoma：topline efficacy and safety results from the randomized phase 3 DEB study

Free
Wei Li Zhao, Jun Zhu, Pengpeng Xu, Yuqin Song, Jianzhen Shen, Qingqing Cai, Hui Zhou, Liling Zhang, Ying Xiang, Xiuhua Sun, Wei Yang, Zhihua Yao, Hongmei Jing, Shujuan Wen, Jie Jin, Hongwei Xue, Hong Cen, Kaiyang Ding, Zhengming Jin, Lihong Liu, Xiaojing Xing, Lanfang Li, Ming Hou, Lin LIU, Mingzhi Zhang, Wenyu Li, Ou Bai, Ru Feng, Zunmin Zhu, Huijing Wu, Liping Su, Li Gao, Fei Li, Wenrong Huang, Peng Liu, Xiaojing Yan, Ying Zhao, Hang Su, Xielan Zhao, Rong FU, Hong Liu, Wenyu Shi
Journal: Blood
Blood (2025) 146 (Supplement 1): 475.
https://doi.org/10.1182/blood-2025-475
Published: 2025
Journal Articles

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

Free
Pengpeng Xu, Huilai Zhang, Ping Li, Hongmei Jing, Yuhuan Gao, Liang Wang, Xu Wei, Rong Fu, Pengcheng He, Liping Su, Shujuan Wen, Yanyan Liu, Xiaojing Yan, Weiyan Tang, Hui Liu, Fang Zhu, Wuping Li, Xiaobing Huang, Tao Wu, Yuhua Li, Xin Zhou, Da Gao, Kailin Xu, Wei Zhang, Xin Li, Yuyang Tian, Yunyue Ju, Yukun Lan, Qian Zhang, Weili Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 6293.
https://doi.org/10.1182/blood-2025-6293
Published: 2025
Journal Articles

Linperlisib Combined with CHOP Regimen Followed By Autologous Hematopoietic Stem Cell Transplantation and Linperlisib Monotherapy Maintenance for Newly Diagnosed Nodal T-Follicular Helper Cell Lymphoma Patients: A Phase II Trial

Free
Weiping Liu, Yao Liu, Zengjun Li, Shujuan Wen, Zhihua Zhang, Liqun Zou, Ming Jiang, Liping Dou, Ou Bai, Jie Yu, Yue Wang, Jie Chen, Yuqin Song, Jun Zhu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6389.
https://doi.org/10.1182/blood-2024-199929
Published: 2024
Journal Articles

Updated Results from a Multicenter, Phase II Study of Zanubrutinib in Combination with Rituximab and Methotrexate, Followed By Zanubrutinib Maintenance in Patients with Secondary Central Nervous System Lymphoma

Free
Lijuan Deng, Tianheng He, Yongjing Tang, Lan Mi, Changyu Lu, Hanxiao Liu, Shupeng Zhong, Jin Chai, Jun Luo, Liling Zhang, Shujuan Wen, Xiaopei Wang, Jun Zhu, Yuqin Song
Journal: Blood
Blood (2024) 144 (Supplement 1): 1735.
https://doi.org/10.1182/blood-2024-209021
Published: 2024
Journal Articles

Anti-PD-1 Antibody (Tislelizumab) Combined with R-CHOP for the Treatment of Previously Untreated Primary Mediastinal B-Cell Lymphoma: A Prospective Phase II Study

Free
Mei Wu, Lin Zhu, Shan Li, Tuerde Jiaerbao, Shanshan Wang, Xiao Liang, Xin Hu, Li Guo, Abulikemujiang Adili, Xianmusiya Maimaitirexiati, Ruirui Ren, Zhihua Yao, Shuna Yao, Shujuan Wen
Journal: Blood
Blood (2023) 142 (Supplement 1): 6236.
https://doi.org/10.1182/blood-2023-182504
Published: 2023